IDT AustraliaASX:IDT OCF Yield % is 4.32 as of Jun. 27, 2026. The stock has 6 warning signs investors should review. Among 1,005 Drug Manufacturers companies, IDT Australia ranks better than 54.13% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
IDT Australia OCF Yield % Related Terms
IDT Australia OCF Yield % Historical Data
* Premium members only.
The historical data trend for IDT Australia's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, IDT Australia's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDT Australia OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, IDT Australia's OCF Yield % distribution charts can be found below:
* The bar in red indicates where IDT Australia's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IDT Australia (ASX:IDT) has a OCF Yield % of 4.32 as of Jun. 27, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on IDT Australia and its competitors. According to the industry distribution chart, IDT Australia ranks #461 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 45.9%.
Is IDT Australia's OCF Yield % too high?
IDT Australia's current OCF Yield % is 4.32. The Drug Manufacturers industry median OCF Yield % is 3.61. IDT Australia's value of 4.32 is 19.7% above this industry median. Based on the distribution chart, IDT Australia ranks #461 out of 1005 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does IDT Australia's OCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, IDT Australia ranks #461 out of 1005 companies for OCF Yield %. This puts IDT Australia in the upper half of its industry. The industry median OCF Yield % is 3.61. IDT Australia's value of 4.32 is 19.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.61, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IDT Australia's current OCF Yield % of 4.32 is 19.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on IDT Australia and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IDT Australia's current OCF Yield % is 4.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDT Australia stock overvalued right now?
Based on GuruFocus' analysis, IDT Australia (ASX:IDT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.17, compared to a current price of A$0.03 — trading 80.6% below its estimated fair value. The current OCF Yield % is 4.32 and 19.7% above the Drug Manufacturers industry median of 3.61. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For IDT Australia (ASX:IDT), the current OCF Yield % is 4.32 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
IDT Australia Ltd produces, develops, and supplies pharmaceutical products. It is engaged in the provision of research and development and other technical services for the pharmaceutical and allied industries. The company is involved in the manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), microbiological and analytical testing, clinical packaging, and pharmacy services. The company operates in Australia, Asia, Europe, and the USA.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:IDT has been successfully added to your 